Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review

AF is common in HCM and associated with high thromboembolic risk. LA dimension and age are independently associated with AF but the literature is insufficient to create robust clinical tools to predict AF or thromboembolism. Most data suggest that AF patients should be anticoagulated.